• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION EVOLUT FX VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION EVOLUT FX VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number EVOLUTFX-34
Device Problems Perivalvular Leak (1457); Device Dislodged or Dislocated (2923)
Patient Problems Valvular Insufficiency/ Regurgitation (4449); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/22/2024
Event Type  Injury  
Manufacturer Narrative
Continuation of d10: product id: d-evolutfx-34; product type: delivery catheter system (dcs); product id: l-evolutfx-34; product type: compression loading system (cls).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Medtronic received information that during the implant of this transcatheter bioprosthetic valve, the valve was implanted.During a post balloon aortic valvuloplasty (bav) with a non-medtronic 23 millimeter (mm) balloon, the patient was rapid paced.There was a loss of pacing capture, which caused the valve to dislodge above the annulus.There was no coronary obstruction and hemodynamics remained stable.A second valve was loaded.The first valve was attempted to be snared into a higher position in the ascending aorta, however was unsuccessful.It was discussed that implanting another evolut fx would be difficult due to the position of the first valve, and there was risk of coronary obstruction and frame interaction.A non-medtronic valve was implanted successfully.The second 34fx valve was not implanted.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Additional information was received indicating that a pre-implant balloon aortic valvuloplasty (bav) was performed using a 23 millimeter (mm) non-medtronic (cristal) balloon.The deployment starting point was at the bottom of the pigtail catheter.Prior to dislodgement, the valve was implanted at a depth of 3mm on the non-coronary cusp (ncc) and 4-5mm on the left coronary cusp (lcc).A post-implant bav was performed due to mild paravalvular leak (pvl), and the valve subsequently dislodged aortic.It was noted that a non-medtronic (safari) guidewire was used during the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT FX VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18976187
MDR Text Key338551664
Report Number2025587-2024-01891
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/25/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberEVOLUTFX-34
Device Catalogue NumberEVOLUTFX-34
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/01/2024
Date Device Manufactured01/30/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-